Nanomaterials In Personalized Medicine Market, By Application Areas (Drug Delivery Systems, Regenerative Medicine, Diagnostics and Imaging, Therapeutics, and Vaccines), By End-users, By Type of Nanomaterials, By Technology Utilized, By Formulation Type, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4516
|
Published Date
November 2025
|
Pages
375
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Nanomaterials In Personalized Medicine Market size was valued at US$ 355,456.34 Million in 2024, expanding at a CAGR of 11.5% from 2025 to 2032.
Nanomaterials in personalized medicine are engineered at the nanoscale to interact precisely with biological systems, enabling healthcare interventions tailored to an individual’s genetic, molecular, or physiological profile. The market is driven by the rising prevalence of chronic diseases and rapid advancements in nanotechnology, which facilitate targeted drug delivery, improved diagnostics, and more effective therapies.
Despite strong growth potential, the sector faces challenges such as high development costs and stringent regulatory requirements. However, significant opportunities exist in developing novel nanomaterials with enhanced properties, integrating AI-driven drug discovery, and expanding into emerging markets. Strategic collaborations among pharmaceutical companies, biotech firms, and academic institutions are essential to unlocking this potential. Governments are also supporting the market: according to the U.S. National Nanotechnology Initiative (NNI), federal funding for nanotechnology research reached USD 1.6 billion in 2024, while the European Commission allocated €1.2 billion in its Horizon Europe program (2021–2027) to advance nanoscale research, demonstrating strong global public-sector backing for nanomaterials in healthcare.
Nanomaterials In Personalized Medicine Market- Market Dynamics
Rising Demand for Personalized Medicine Driving Market Growth
The increasing adoption of personalized medicine is expected to significantly propel the growth of nanomaterials in healthcare. Personalized medicine tailors treatments to individual patients based on genetic, environmental, and lifestyle factors, optimizing therapeutic outcomes and enhancing overall care. Advances in genomic technologies are enabling precise identification of genetic variations, allowing for highly targeted and patient-specific therapies.
Nanomaterials play a crucial role in this evolution by facilitating targeted drug, gene, and RNA delivery, improving treatment efficacy while minimizing side effects. Their ability to deliver therapies directly to specific cells or tissues enhances both safety and therapeutic outcomes. According to the Personalized Medicine Coalition (PMC), the FDA approved 26 new personalized medicines in 2023, up from 12 in 2022, highlighting the accelerating demand for tailored treatments. This surge in personalized medicine adoption is directly driving the development and application of nanomaterials within the sector.
Nanomaterials In Personalized Medicine Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Application Areas, End-users, Type of Nanomaterials, Technology Utilized, Formulation Type, and Region.
The Formulation Type segment in the nanomaterials market for personalized medicine is primarily classified into Nanoparticles, Nanocrystals, Nanosuspensions, Nanoemulsions, and Nanoformulations for Targeted Delivery. Among these, nanoparticles are particularly critical, serving as a cornerstone for targeted drug delivery, cancer therapy, and diagnostic applications. Their unique ability to overcome biological barriers and deliver therapeutic agents directly to diseased cells makes them highly valuable in precision medicine. For example, in April 2025, Marama Labs launched CloudSpec, an instrument capable of rapidly quantifying drug payloads in lipid nanoparticles, enabling precise RNA and DNA measurements in just 15 seconds, highlighting advancements in nanoparticle characterization.
From the Application Area perspective, Drug Delivery Systems represent a major segment within nanomaterials for personalized medicine. Nano-enabled carriers, particularly lipid nanoparticles (LNPs), facilitate precise, efficient, and safe delivery of personalized therapies—including mRNA, siRNA, and gene-editing agents—directly to target cells, while preserving fragile nucleic acids and minimizing off-target effects. A notable example is Acuitas Therapeutics, a leader in LNP technology, which in 2025 presented preclinical data for next-generation LNPs featuring DARPin-conjugated ligands for targeted mRNA delivery to T-cells, demonstrating repeat-dosing safety and extrahepatic targeting. Additionally, in May 2024, Aldevron partnered with Acuitas to leverage its LNP platform for mRNA sequence-to-vial manufacturing, substantially expanding production capacity for personalized RNA therapies. This combination of advanced formulations and targeted delivery systems underscores the growing impact of nanomaterials on the efficacy and precision of personalized medicine.
Nanomaterials In Personalized Medicine Market- Geographical Insights
Asia Pacific holds a significant share of the nanomaterials in personalized medicine market, driven by strong government support, expanding biotechnology infrastructure, and rising healthcare investments. Countries such as China, India, Japan, and South Korea are leading the way, implementing national programs that promote nanotechnology research and precision medicine development. The growing prevalence of chronic and genetic diseases further fuels demand for personalized nanomedicines. Additionally, an expanding middle class and improved access to advanced healthcare services are accelerating the adoption of nano-enabled diagnostics and therapeutics. According to the Organisation for Economic Co-operation and Development (OECD, 2024), government spending on biotechnology and nanomedicine R&D reached USD 12.7 billion globally, reflecting strong public-sector support for innovation in personalized medicine. With rapid growth in R&D capabilities and commercial manufacturing, Asia Pacific is emerging as a hub for innovation, market expansion, and cutting-edge personalized medicine solutions.
Japan Nanomaterials In Personalized Medicine Market- Country Insights
Japan is rapidly establishing itself as a major center for nanomedicine innovation, supported by strong government R&D funding and a mature biotechnology infrastructure. The Japan Nanomedicine Society actively promotes collaboration between academia, industry, and healthcare stakeholders to advance nanomaterial-based therapies for personalized medicine. In April 2024, Nanoform Finland partnered with Japanese pharmaceutical company CBC Co., Ltd. to introduce Nanoform’s nanoparticle-engineering platform to Japan, aiming to enhance drug bioavailability and reduce patient dosing requirements. Additionally, the Innovation Center of NanoMedicine (iCONM) in Kawasaki is driving cutting-edge research; in mid-2025, researchers developed a nanomedicine capable of delivering antisense nucleic acids to lymph nodes to inhibit cancer metastases, highlighting Japan’s growing leadership in next-generation personalized therapies.
Nanomaterials In Personalized Medicine Market- Competitive Landscape:
The Nanomaterials in Personalized Medicine Market is moderately concentrated, with key players such as Evonik Industries AG, OncoNano Medicine Inc., and Merck KGaA leading innovation. Evonik focuses on developing lipid-based nanocarriers for cancer therapies, OncoNano Medicine specializes in gold nanoparticle platforms for precise drug delivery and imaging, and Merck KGaA utilizes polymer-based nanomaterials for targeted gene therapies and personalized prophylactic treatments. These companies compete on enhancing nanocarrier biocompatibility, stability, and targeting efficiency, while leveraging strategic partnerships, clinical collaborations, and scale-up initiatives to drive innovation. Rising demand for tailored therapies is encouraging heavy R&D investment and commercialization strategies to maintain leadership in precision nanomedicine.
Recent Developments:
- In June 2023, Bayer AG partnered with Acuitas Therapeutics Inc. to access its lipid nanoparticle (LNP) delivery technology, advancing Bayer’s in vivo gene-editing and protein-replacement programs. The collaboration leverages Acuitas’ expertise in efficient, targeted RNA delivery, particularly to the liver.
- In September 2023, Evonik enhanced its parenteral drug delivery portfolio with three new PLA-PEG di-block copolymers (RESOMER RP d) and a nanoparticle formulation service using sonication technology. These copolymers facilitate nanoparticle formation and controlled drug release, while the nanosonication process enables cGMP-compliant nanoparticle production, addressing critical manufacturing challenges in drug delivery.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Merck KGaA Darmstadt Germany
- OncoNano Medicine Inc.
- Molecular Rebar Design Inc
- Cello Therapeutics Inc.
- Evonik Industries AG
- Eisai Co. Ltd.
- TÜV Rheinland AG
- OCSiAl S.A
- Sanofi S.A.
- The Bristol-Myers Squibb Company
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- American Elements Inc.
- Pfizer & Co. Inc
- BASF SE
- Cour Pharmaceuticals Inc.
- Nanocomposix Inc
- NoPo Nanotechnologies Private Limited
- Matexcel Biotech Inc.
- Apurano Pharmaceuticals GmbH
- SGN Nanopharma Inc.
- Others
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY APPLICATION AREAS- MARKET ANALYSIS, 2019 - 2032
- Drug Delivery Systems
- Regenerative Medicine
- Diagnostics and Imaging
- Therapeutics
- Vaccines
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Biotechnology Firms
- Academic Institutions
- Research Laboratories
- Pharmaceutical Companies
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TYPE OF NANOMATERIALS- MARKET ANALYSIS, 2019 - 2032
- Carbon-based Nanomaterials
- Nanostructured Materials
- Metallic Nanoparticles
- Polymeric Nanomaterials
- Silica Nanoparticles
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TECHNOLOGY UTILIZED- MARKET ANALYSIS, 2019 - 2032
- Nanofabrication Techniques
- Molecular Imaging Techniques
- Nanotechnology-based Screening Methods
- Bioconjugation Methods
- Surface Modification Techniques
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032
- Nanoparticles
- Nanocrystals
- Nanosuspensions
- Nanoemulsions
- Nanoformulations for Targeted Delivery
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Nanomaterials In Personalized Medicine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Nanomaterials In Personalized Medicine Market Snippet by Application Areas
2.1.2. Nanomaterials In Personalized Medicine Market Snippet by End-users
2.1.3. Nanomaterials In Personalized Medicine Market Snippet by Type of Nanomaterials
2.1.4. Nanomaterials In Personalized Medicine Market Snippet by Technology Utilized
2.1.5. Nanomaterials In Personalized Medicine Market Snippet by Formulation Type
2.1.6. Nanomaterials In Personalized Medicine Market Snippet by Country
2.1.7. Nanomaterials In Personalized Medicine Market Snippet by Region
2.2. Competitive Insights
3. Nanomaterials In Personalized Medicine Key Market Trends
3.1. Nanomaterials In Personalized Medicine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Nanomaterials In Personalized Medicine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Nanomaterials In Personalized Medicine Market Opportunities
3.4. Nanomaterials In Personalized Medicine Market Future Trends
4. Nanomaterials In Personalized Medicine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Nanomaterials In Personalized Medicine Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Nanomaterials In Personalized Medicine Market Landscape
6.1. Nanomaterials In Personalized Medicine Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Nanomaterials In Personalized Medicine Market – By Application Areas
7.1. Overview
7.1.1. Segment Share Analysis, By Application Areas, 2024 & 2032 (%)
7.1.2. Drug Delivery Systems
7.1.3. Regenerative Medicine
7.1.4. Diagnostics and Imaging
7.1.5. Therapeutics
7.1.6. Vaccines
8. Nanomaterials In Personalized Medicine Market – By End-users
8.1. Overview
8.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
8.1.2. Hospitals & Clinics
8.1.3. Biotechnology Firms
8.1.4. Academic Institutions
8.1.5. Research Laboratories
8.1.6. Pharmaceutical Companies
9. Nanomaterials In Personalized Medicine Market – By Type of Nanomaterials
9.1. Overview
9.1.1. Segment Share Analysis, By Type of Nanomaterials, 2024 & 2032 (%)
9.1.2. Carbon-based Nanomaterials
9.1.3. Nanostructured Materials
9.1.4. Metallic Nanoparticles
9.1.5. Polymeric Nanomaterials
9.1.6. Silica Nanoparticles
10. Nanomaterials In Personalized Medicine Market – By Technology Utilized
10.1. Overview
10.1.1. Segment Share Analysis, By End-users, 2024 & 2032 (%)
10.1.2. Nanofabrication Techniques
10.1.3. Molecular Imaging Techniques
10.1.4. Nanotechnology-based Screening Methods
10.1.5. Bioconjugation Methods
10.1.6. Surface Modification Techniques
11. Nanomaterials In Personalized Medicine Market – By Formulation Type
11.1. Overview
11.1.1. Segment Share Analysis, By Formulation Type, 2024 & 2032 (%)
11.1.2. Nanoparticles
11.1.3. Nanocrystals
11.1.4. Nanosuspensions
11.1.5. Nanoemulsions
11.1.6. Nanoformulations for Targeted Delivery
12. Nanomaterials In Personalized Medicine Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Nanomaterials In Personalized Medicine Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Nanomaterials In Personalized Medicine Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Nanomaterials In Personalized Medicine Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Nanomaterials In Personalized Medicine Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Nanomaterials In Personalized Medicine Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Application Areas, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By End-users, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Type of Nanomaterials, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Technology Utilized, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By Formulation Type, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Nanomaterials In Personalized Medicine Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Merck KGaA Darmstadt Germany
13.2.2. OncoNano Medicine Inc.
13.2.3. Molecular Rebar Design Inc
13.2.4. Cello Therapeutics Inc.
13.2.5. Evonik Industries AG
13.2.6. Eisai Co. Ltd.
13.2.7. TÜV Rheinland AG
13.2.8. OCSiAl S.A
13.2.9. Sanofi S.A.
13.2.10. The Bristol-Myers Squibb Company
13.2.11. Thermo Fisher Scientific Inc.
13.2.12. Abbott Laboratories
13.2.13. American Elements Inc.
13.2.14. Pfizer & Co. Inc
13.2.15. BASF SE
13.2.16. Cour Pharmaceuticals Inc.
13.2.17. Nanocomposix Inc
13.2.18. NoPo Nanotechnologies Private Limited
13.2.19. Matexcel Biotech Inc.
13.2.20. Apurano Pharmaceuticals GmbH
13.2.21. SGN Nanopharma Inc.
13.2.22. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Merck KGaA Darmstadt Germany
- OncoNano Medicine Inc.
- Molecular Rebar Design Inc
- Cello Therapeutics Inc.
- Evonik Industries AG
- Eisai Co. Ltd.
- TÜV Rheinland AG
- OCSiAl S.A
- Sanofi S.A.
- The Bristol-Myers Squibb Company
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- American Elements Inc.
- Pfizer & Co. Inc
- BASF SE
- Cour Pharmaceuticals Inc.
- Nanocomposix Inc
- NoPo Nanotechnologies Private Limited
- Matexcel Biotech Inc.
- Apurano Pharmaceuticals GmbH
- SGN Nanopharma Inc.
- Others
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY APPLICATION AREAS- MARKET ANALYSIS, 2019 - 2032
- Drug Delivery Systems
- Regenerative Medicine
- Diagnostics and Imaging
- Therapeutics
- Vaccines
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Biotechnology Firms
- Academic Institutions
- Research Laboratories
- Pharmaceutical Companies
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TYPE OF NANOMATERIALS- MARKET ANALYSIS, 2019 - 2032
- Carbon-based Nanomaterials
- Nanostructured Materials
- Metallic Nanoparticles
- Polymeric Nanomaterials
- Silica Nanoparticles
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY TECHNOLOGY UTILIZED- MARKET ANALYSIS, 2019 - 2032
- Nanofabrication Techniques
- Molecular Imaging Techniques
- Nanotechnology-based Screening Methods
- Bioconjugation Methods
- Surface Modification Techniques
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY FORMULATION TYPE- MARKET ANALYSIS, 2019 - 2032
- Nanoparticles
- Nanocrystals
- Nanosuspensions
- Nanoemulsions
- Nanoformulations for Targeted Delivery
GLOBAL NANOMATERIALS IN PERSONALIZED MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
